Skip to main content
TipRanks
Go Ultimate75% OFF

Merit Medical Systems (MMSI) Ratios

351 Followers

Merit Medical Systems Ratios

MMSI's free cash flow for Q3 2026 was $52.25M. For the 2026 fiscal year, MMSI's free cash flow was decreased by $-13.02M and operating cash flow was $65.27M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio4.344.275.452.402.04
Quick Ratio2.952.853.951.191.10
Cash Ratio1.871.742.880.260.29
Solvency Ratio0.240.230.170.320.24
Operating Cash Flow Ratio1.241.020.710.520.62
Short-Term Operating Cash Flow Coverage27.340.000.005.147.71
Net Current Asset Value$ -61.47M$ -115.47M$ -14.77M$ 9.52M$ -126.28M
Leverage Ratios
Debt-to-Assets Ratio0.330.330.380.170.20
Debt-to-Equity Ratio0.570.580.740.240.31
Debt-to-Capital Ratio0.360.370.430.200.24
Long-Term Debt-to-Capital Ratio0.340.350.410.140.18
Financial Leverage Ratio1.701.751.931.451.59
Debt Service Coverage Ratio7.767.8313.626.056.14
Interest Coverage Ratio6.974.997.9913.8111.58
Debt to Market Cap0.160.130.190.050.07
Interest Debt Per Share15.6314.1915.755.045.89
Net Debt to EBITDA1.351.531.331.221.66
Profitability Margins
Gross Profit Margin48.65%47.43%46.44%45.10%45.16%
EBIT Margin13.03%11.74%10.15%7.73%5.51%
EBITDA Margin21.92%20.20%18.20%15.74%14.42%
Operating Profit Margin12.17%11.48%9.86%7.61%5.67%
Pretax Profit Margin11.28%11.06%8.91%7.18%5.02%
Net Profit Margin8.48%8.87%7.51%6.47%4.51%
Continuous Operations Profit Margin8.48%8.87%7.51%6.47%4.51%
Net Income Per EBT75.17%80.24%84.23%90.18%89.87%
EBT Per EBIT92.71%96.34%90.44%94.37%88.51%
Return on Assets (ROA)4.78%4.98%4.06%4.48%2.94%
Return on Equity (ROE)8.11%8.73%7.85%6.51%4.66%
Return on Capital Employed (ROCE)7.54%7.07%5.84%6.07%4.31%
Return on Invested Capital (ROIC)5.64%5.65%4.89%5.35%3.80%
Return on Tangible Assets7.83%8.26%5.84%7.25%5.01%
Earnings Yield2.46%2.14%2.16%1.86%1.39%
Efficiency Ratios
Receivables Turnover6.776.496.646.456.22
Payables Turnover12.8510.4110.219.2210.60
Inventory Turnover2.332.332.222.382.66
Fixed Asset Turnover2.943.002.822.572.46
Asset Turnover0.560.560.540.690.65
Working Capital Turnover Ratio2.011.682.074.154.38
Cash Conversion Cycle182.07177.86183.88170.67161.68
Days of Sales Outstanding53.8856.2854.9456.5958.70
Days of Inventory Outstanding156.60156.64164.68153.65137.43
Days of Payables Outstanding28.4235.0635.7439.5734.45
Operating Cycle210.48212.92219.62210.24196.13
Cash Flow Ratios
Operating Cash Flow Per Share5.033.792.522.012.62
Free Cash Flow Per Share3.593.141.881.222.12
Dividend Paid and CapEx Coverage Ratio3.515.803.952.545.27
Capital Expenditure Coverage Ratio3.515.803.952.545.27
Operating Cash Flow Coverage Ratio0.330.280.160.410.45
Operating Cash Flow to Sales Ratio0.200.160.120.100.14
Free Cash Flow Yield4.08%3.25%2.48%1.73%3.41%
Valuation Ratios
Price-to-Earnings (P/E) Ratio40.6246.7246.3453.8472.19
Price-to-Sales (P/S) Ratio3.444.153.483.493.25
Price-to-Book (P/B) Ratio3.294.083.643.513.36
Price-to-Free Cash Flow (P/FCF) Ratio24.5330.8140.3457.9229.32
Price-to-Operating Cash Flow Ratio17.5325.5030.1435.1023.76
Price-to-Earnings Growth (PEG) Ratio8.411.781.841.03-0.12
Enterprise Value Multiple17.0622.0820.4423.3724.24
Enterprise Value5.66B6.05B4.68B4.23B3.76B
EV to EBITDA17.0622.0820.4423.3724.24
EV to Sales3.744.463.723.683.49
EV to Free Cash Flow26.6533.1043.1561.1231.48
EV to Operating Cash Flow19.0527.4032.2437.0425.51
Tangible Book Value Per Share9.127.178.588.966.39
Shareholders’ Equity Per Share26.7823.6920.8720.1518.52
Tax and Other Ratios
Effective Tax Rate0.250.200.160.100.10
Revenue Per Share25.6023.3021.8320.2619.14
Net Income Per Share2.172.071.641.310.86
Tax Burden0.750.800.840.900.90
Interest Burden0.870.940.880.930.91
Research & Development to Revenue0.060.060.070.070.07
SG&A to Revenue0.300.280.000.000.00
Stock-Based Compensation to Revenue0.030.020.020.020.01
Income Quality2.311.831.541.533.04

Currency in USD